The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats

Cell Biology and Toxicology

Volumn 24, Issue 1, 2008, Pages 63-73

  Hamza, A ^a   Amin, A ^a   Daoud, S ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b TAWAM HOSPITAL   (United Arab Emirates)

Author keywords

Apoptosis; Cardiotoxicity; Doxorubicin; Protection; Withania

Indexed keywords

CALCIUM; CARBONYL DERIVATIVE; CATALASE; DOXORUBICIN; MALONALDEHYDE; PROTEIN BCL 2; SODIUM CHLORIDE; WITHANIA SOMNIFERA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOTOXICITY; ENZYME ACTIVITY; HEART MUSCLE NECROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WITHANIA SOMNIFERA;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; CALCIUM; CELL DEATH; DOXORUBICIN; HEART; IN SITU NICK-END LABELING; MALE; MALONDIALDEHYDE; MYOCARDIUM; PEROXIDASE; PLANT EXTRACTS; PROTECTIVE AGENTS; PROTEIN CARBONYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; WITHANIA;

RATTUS; RATTUS NORVEGICUS; WITHANIA; WITHANIA SOMNIFERA;

EID: 37749007703     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-007-9016-z     Document Type: Article

References (36)

1. Abdel-Wahab MH, El-Mahdy MA, Abd-Ellah MF, Helat GK, Khalifa F, Hamada FMA. Influence of p-coumaric acid on doxorubicin-induced oxidative stress in rat heart. Pharmacol Res 2003;48:461-5.
2. Aebi H. Catalase. Methods Enzymol 1984;105:121-6.
3. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of (antioxidant power): The FRAP assay. Anal Biochem 1996;293:70-6.
4. Chaurasia SS, Panda S, Kar A. Withania somnifera root extracts in the regulation of lead-induced oxidative damage in male mouse. Pharmacol Res 2000;41:663-6.
5. Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C. Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res 2002;62:4592-8.
6. Choudhary MI, Nawaz SA, ul-Haq Z, et al. Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties. Biochem Biophys Res Commun 2005;334:276-87.
7. Dalloz F, Maingon P, Cottin Y, Briot F, Horiot JC, Rochette L. Effect of combined irradiation and doxorubicin treatment on cardiac function and antioxidant defenses in the rat. Free Radic Biol Med 1999;26:785-800.
8. Davis L, Kuttan G. Suppressive effect of cyclophosphamide-induced toxicity by Withania somnifera extract in mice. J Ethnopharmacol 1998;62:209-14.
9. Davis L, Kuttan G. Effect of Withania somnifera on cyclophosphamide- induced urotoxicity. Cancer Lett 2000;148:9-17.
10. Dhuley JN. Adaptogenic and cardioprotective action of ashwagandha in rats and frogs. J Ethnopharmacol 2000;70:57-63.
11. Ermak G, Davies KJA. Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 2001;38:713-21.
12. Fujimura L, Matsudo Y, Kang M, Takamori Y, Tokuhisa T, Hatano M. Protective role of Nd1 in doxorubicin-induced cardiotoxicity. Cardiovasc Res 2004;64:315-21.
13. Gille L, Nohl H. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic Biol Med 1997;23:775-82.
14. Gupta SK, Dua A, Vohra BP. Withania somnifera (Ashwagandha) attenuates antioxidant defense in aged spinal cord and inhibits copper induced lipid peroxidation and protein oxidative modifications. Drug Metab Drug Interact 2003;19:211-22.
15. Hillegas LM, Griswold DE, Brickson B, Albrightson-Winslow C. Assessment of myloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990;24:285-95.
16. Jang YM, Kendaiah S, Drew B, et al. Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats. FEBS Lett 2004;577:483-90.
17. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology 2000;7:153-63.
18. Klebanoff SJ. Myloperoxidase. Proc Assoc Am Physicians 1999;111:383-9.
19. Minotti G, Parlani M, Salvatorelli E, et al. Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogue. Br J Pharmacol 2001;134(6):1271-8.
20. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 2000;5:334-46.
21. Mizutani H, Tada-Oikawa S, Hiraku Y, Kojima M, Kawanishi S. Mehanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci 2005;76:1439-53.
22. Mohanty I, Arya DS, Dinda A, Talwar KK, Joshi S, Gupta SK. Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infraction. Basic Clin Pharmacol Toxicol 2004;94:184-90.
23. Mukherjee S, Banerjee SK, Maulik M, Dinda AK, Maulik KS. Protection against acute adriamycin-induced cardiotoxicity by garlic endogenous antioxidants and inhibition of TNF-alpha expression. BMC Pharmacol 2003;3:1-9.
24. Nicholls S, Hazen SL. Myloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 2005;25:274-8.
25. Oliveira PJ, Bjork JA, Santos MS, et al. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicol Appl Pharmacol 2004;200:159-68.
26. Padmavathi B, Rath PC, Rao AR, Singh RP. Roots of Withania somnifera inhibit forestomach and skin carcinogenesis in mice. eCAM 2005;2:99-105.
27. Peterson GL. A simplification of the protein assay method of Lowry et al which is more generally applicable. Anal Biochem 1977;83:346-56.
28. Rasool M, Varalakshmi P. Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study. Vascul Pharmacol 2006;44:406-10.
29. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357-63.
30. Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 2000;71, 23-43.
31. Sorg O. Oxidative stress: a theoretical model for a biological reality. Comptes Rendus Biol 2004;327:649-62.
32. Sun M, Zigman S. An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation. Anal Biochem 1978;247:81-9.
33. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-8.
34. Waring P. Redox active calcium ion channels and cell death. Arch Biochem Biophys 2005;434:33-42.
35. Yagmurca M, Fadillioglu E, Erdogan H, Ucar M, Sogut S, Irmak MK. Erdosterine prevents doxorubicin-induced cardiotoxicity. Pharmacol Res 2003;48:377-82.
36. Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology 2006;218:164-71.